Top Markets
Coin of the day
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Rank in Stocks #18095
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Share Price
$10.22
Last synced: 2026-07-31
Market Cap
$212.97M
Change (1 day)
4.58%
Change (1 year)
78.08%
Country
CA
Trade Satellos Bioscience Inc. (MSCL)

Category

Stock price history for Satellos Bioscience Inc. (MSCL)
Highest end of day price: $9.26 on 2026-07-01

Lowest end of day price: $152.54 on 2008-01-01
Stock price history of Satellos Bioscience Inc. from 2008 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 29.26%
2025 -20.28%
2024 84.25%
2023 91.27%
2022 -80.10%
2021 2.79%
2020 -11.41%
2019 10.94%
2018 37.66%
2017 -27.41%
2016 41.02%
2015 -8.55%
2014 -90.26%
2013 -52.35%
2012 195.82%
2011 -36.68%
2010 -30.40%
2009 333.63%
2008 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.68 -9.23%
AU
$757.71 6.76%
CH